Price $270.95 |
Market Cap
8.96B
|
Sector Health Care |
Div. Growth
-
|
P/E
19.3
|
P/B
2.87
|
P/S
2.23
|
Dividend %
-
|
P/CF
-
|
P/FCF
32.3
|
Op. Cash Flow
625K
|
FCF
5.6
|
Op. Margin
18.50%
|
Net Margin
11.60%
|
ROE
16.20%
|
ROI
9.50%
|
ROA
6.40%
|
EPS Growth
8.30%
|
Current Ratio
1.3
|
Debt/Equity
91.00%
|
Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
---|---|---|---|---|---|
Cidara Therapeutics Inc (CDTX) | $0.92 | - | - | 78M | Strong Buy |
Interpace Biosciences Inc (IDXG) | $1.50 | - | - | 4.1M | Strong Buy |
Jazz Pharmaceuticals PLC (JAZZ) | $120.42 | - | - | 8.13B | Strong Buy |
Bimi International Medical Inc (BIMI) | $1.68 | - | - | 6.4M | Strong Buy |
Journey Medical Corp (DERM) | $3.68 | - | - | 43.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More